Catalyst Wire Dossier Catalyst Wire Dossier

Myrin 2

rifampicin + isoniazid fixed-dose combination
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Myrin 2, covering 2012-07-30 to 2012-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) [Phase 1]

See pricing